SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3476Motley Fool Isis' 2G Drug Shines Tuesday January 6, 10:03 am ET By David Nibob zagorin-1/7/2004
3475Whatever happens. it's going to take a while: <i>Isis plans to initiatnigel bates-1/6/2004
3474did you all miss the following paragraph or just not believe it? "...We arbob zagorin-1/6/2004
3473>>This doesn't look like they hit it out of the statistical ball park tuck-1/5/2004
3472This doesn't look like they hit it out of the statistical ball park here. LThe Band Leader-1/5/2004
3471Isis Pharmaceuticals Reports Positive Data from Phase 2 Trial Of ISIS 104838 in nigel bates-1/5/2004
3470reiterated today ISIS Pharma ISIS Roth Capital Buy $10.50bob zagorin-12/29/2003
3469Isis Pharmaceuticals Initiates Phase I Study of Second-Generation Antisense Drugbob zagorin-12/29/2003
3468>>CARLSBAD, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Isis Pharmaceuticalstuck-12/17/2003
3467Antisense Drug Targeting Survivin Inhibits Growth Of Tumors In Animal Models; Dabob zagorin-11/20/2003
3466reit. today ISIS Pharm ISIS Roth Capital Buy $10.50bob zagorin-11/6/2003
3465Isis Pharmaceuticals Reports Third Quarter 2003 Highlights And Financial Resultsbob zagorin-11/4/2003
3464Isis Pharmaceuticals Broadens Micro-RNA Drug Discovery Program With Support Frombob zagorin-11/3/2003
3463excerpt from wall street transcript interview with rodman and redman (sp) bio anbob zagorin-10/27/2003
3462>>CARLSBAD, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Isis Pharmaceuticalstuck-10/27/2003
3461Isis Pharmaceuticals' Ibis Program Receives $6 Million Grant from the CDC fonigel bates-10/7/2003
3460Isis Optimistic About Latest Antisense Compounds Thu September 18, 2003 07:53 AMbob zagorin-9/18/2003
3459Second-Generation Antisense Drug ISIS 104838 Reduces TNF-alpha In Rheumatoid Artbob zagorin-9/18/2003
3458Its all good finally my accumulation at the 5 level is paying off. I also have krjk01-9/17/2003
3457Second-Generation Type 2 Diabetes Antisense Drug Improves Glucose Tolerance Testbob zagorin-9/16/2003
3456OncoGenex Technologies and Isis Pharmaceuticals Expand Antisense Anti-Cancer Drubob zagorin-9/9/2003
3455Hybridon Receives Patent Further Expanding Proprietary Position For Oral Adminisbob zagorin-9/4/2003
3454Amersham Biosciences' OligoProcess Assists Isis Pharmaceuticals in Achievingbob zagorin-9/4/2003
3453Antisense Therapeutics Limited and Isis Pharmaceuticals Initiate Phase I Trial obob zagorin-8/27/2003
3452any listen to the call and care to post notes. i haven't had a chance to lisbob zagorin-8/5/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News